Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Richter

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.
Theranostics|August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagyAnna Mukha, Uğur Kahya, Annett Linge, et al.
Endocrine-Related Cancer|March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary culturesKatharina Wang, Ina Schütze, Sebastian Gulde, et al.
Metabolism: Clinical and Experimental|June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsSudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Metabolites|July 27, 2022
Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine HypertensionNikolaos G Bliziotis, Leo A J Kluijtmans, Gerjen H Tinnevelt, et al.
American Journal of Human Genetics|December 20, 2016
Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe EncephalopathySamira Ait-El-Mkadem, Manal Dayem-Quere, Mirjana Gusic, et al.
The Journal of Molecular Diagnostics : JMD|May 30, 2017
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma DiagnosticsMaria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.
Theranostics|August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagyAnna Mukha, Uğur Kahya, Annett Linge, et al.
Endocrine-Related Cancer|March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary culturesKatharina Wang, Ina Schütze, Sebastian Gulde, et al.
Metabolism: Clinical and Experimental|June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsSudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Metabolites|July 27, 2022
Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine HypertensionNikolaos G Bliziotis, Leo A J Kluijtmans, Gerjen H Tinnevelt, et al.
American Journal of Human Genetics|December 20, 2016
Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe EncephalopathySamira Ait-El-Mkadem, Manal Dayem-Quere, Mirjana Gusic, et al.
The Journal of Molecular Diagnostics : JMD|May 30, 2017
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma DiagnosticsMaria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, et al.
Pageof 9